The mRNA expression of TIPE2, Foxp3, and CTLA-4 in peripheral blood mononucleated cells in patients with chronic hepatitis C and their clinical significance

Kong Li; Jin Meng; Wang WeiZhen; Zhao SuXian; Wang ShanShan

doi:10.3969/j.issn.1001-5256.2019.02.016

Volume 35 Issue 2

Feb. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(2): 323-327

PDF( 2049 KB)

The mRNA expression of TIPE2, Foxp3, and CTLA-4 in peripheral blood mononucleated cells in patients with chronic hepatitis C and their clinical significance

DOI: 10.3969/j.issn.1001-5256.2019.02.016

Department of Hepatology, Third Hospital of Hebei Medical University

Research funding:

Published Date: 2019-02-20

Abstract

Abstract

Objective To investigate the mRNA expression of tumor necrosis factor-alpha-induced protein 8-like 2 ( TIPE2) , Foxp3 ( a functional molecule for regulatory T cells) , and cytotoxic T-lymphocyte-associated antigen 4 ( CTLA-4) in peripheral blood mononuclear cells ( PBMCs) in patients with chronic hepatitis C ( CHC) and their clinical significance. Methods A total of 80 CHC patients who were hospitalized in The Third Hospital of Hebei Medical University from May 2012 to December 2016 and did not receive antiviral drugs or immunoregulatory drugs were enrolled as CHC group, and 45 healthy volunteers were enrolled as controls. Quantitative real-time PCR was used to measure the mRNA expression of TIPE2, Foxp3, and CTLA-4 in PBMCs; the correlation between liver biochemical parameters and HCV RNA was observed, as well as the influence of TIPE2 on Foxp3 and CTLA-4. The t-test was used for comparison of continuous data between two groups, the chi-square test was used for comparison of categorical data between two groups, and Pearson correlation was used for correlation analysis. Results Compared with the healthy control group, the CHC group had a significant reduction in the mRNA expression of TIPE2 ( 0. 564 ± 0. 232 vs 0. 704 ± 0. 165, t = 3. 569, P < 0. 001) and significant increases in the mRNA expression of Foxp3 ( 0. 701 ± 0. 405 vs 0. 527 ± 0. 184, t = 2. 725, P = 0. 007) and CTLA-4 ( 0. 638 ± 0. 211 vs 0. 448 ± 0. 134, t = 5. 449, P < 0. 001) . The mRNA expression of TIPE2 was negatively correlated with serum alanine aminotransferase ( r =-0. 368, P = 0. 001) , aspartate aminotransferase ( r =-0. 417, P < 0. 001) , total bilirubin ( r =-0. 416, P < 0. 001) , and HCV RNA load ( r =-0. 327, P = 0. 003) and was positively correlated with the mRNA expression of Foxp3 ( r = 0. 461, P < 0. 001) and CTLA-4 ( r = 0. 257, P = 0. 021) . The mRNA expression of Foxp3 was negatively correlated with total bilirubin ( r =-0. 284, P = 0. 011) . Conclusion CHC patients have abnormalities in the mRNA expression of TIPE2 and the mRNA expression and function of Foxp3 and CTLA-4, which is associated with the degree of hepatocellular injury and viral replication. The TIPE2 gene may be involved in the pathogenesis of CHC by positively regulating immune response mediated by regulatory T cells.
- hepatitis C, chronic,
- TIPE2,
- forkhead transcription factors,
- CTLA-4,
- peripheral blood mononuclear cell

FullText(HTML)

References(24)

References

[1]SUN H, GONG S, CARMODY RJ, et al.TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis[J].Cell, 2008, 133 (3) :415-426.

[2]KONG L, LIU K, ZHANG YZ, et al.Downregulation of TIPE2mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C[J].Hepatol Int, 2013, 7 (3) :844-849.

[3]SAKAGUCHI S, SAKAGUCHI N, ASANO M, et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) .Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol, 1995, 155 (3) :1151-1164.

[4]NAFADY A, NAFADY-HEGO H, ABDEWAHAB NM, et al.Peripheral lymphocytes analyses in children with chronic hepatitis Cvirus infection[J].Eur J Clin Invest, 2018, 48 (10) :e13004.

[5]EBINUMA H, NAKAMOTO N, LI Y, et al.Identification and in vitro expansion of functional antigen-specific CD25+Fox P3+regulatory T cells in hepatitis C virus infection[J].J Virol, 2008, 82 (10) :5043-5053.

[6]ZHAI N, LI H, SONG H, et al.Hepatitis C virus induces MD-SCs-like monocytes through TLR2/PI3K/AKT/STAT3 signaling[J].PLo S One, 2017, 12 (1) :e0170516.

[7]LUAN YY, YAO YM, ZHANG L, et al.Expression of tumor necrosis factor-αinduced protein 8 like-2 contributes to the immunosuppressive property of CD4+CD25+regulatory T cells in mice[J].Mol Immunol, 2011, 49 (1-2) :219-226.

[8]ZHANG L, SHI Y, WANG Y, et al.The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation[J].Mol Immunol, 2011, 48 (9-10) :1209-1215.

[9]FONTENOT JD, GAVIN MA, RUDENSKY AY.Foxp3 programs the development and function of CD4+CD25+regulatory Tcells[J].Nat Immunol, 2003, 4 (4) :330-336.

[10]RUDENSKY AY.Regulatory T cells and Foxp3[J].Immunol Rev, 2011, 241 (1) :260-268.

[11]PASSERINI L, BACCHETTA R.Forkhead-box-P3 gene transfer in human CD4+T conventional cells for the generation of stable and efficient regulatory T Cells, suitable for immune modulatory therapy[J].Front Immunol, 2017, 8:1282.

[12]KITAGAWA Y, SAKAGUCHI S.Molecular control of regulatory T cell development and function[J].Curr Opin Immunol, 2017, 49:64-70.

[13]SMYK-PEARSON S, GOLDEN-MASON L, KLARQUIST J, et al.Functional suppression by FoxP3+CD4+CD25high regulatory T cells during acute hepatitis C virus infection[J].J Infect Dis, 2008, 197 (1) :46-57.

[14]GUO FB, WU JZ, AI LM, et al.Clinical significance of Th17/Treg and associated cytokines in peripheral blood in chronic hepatitis C patients with liver cirrhosis[J].J Clin Hepatol, 2017, 33 (3) :479-484. (in Chinese) 郭飞波, 武军驻, 艾黎明, 等.慢性丙型肝炎肝硬化患者外周血辅助性T淋巴细胞17/调节性T淋巴细胞及相关因子检测的临床意义[J].临床肝胆病杂志, 2017, 33 (3) :479-484.

[15]CLAASSEN MA, de KNEGT RJ, TILANUS HW, et al.Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J].J Hepatol, 2010, 52 (3) :315-321.

[16]ISHIBASHI M, YAMAGUCHI H, HIROTANI Y, et al.Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers[J].Arch Virol, 2018, 163 (4) :855-865.

[17]AMORAS EDA S, GOMES ST, FREITAS FB, et al.Intrahepatic mRNA expression of FAS, FASL, and FOXP3 genes is associated with the pathophysiology of chronic HCV infection[J].PLo S One, 2016, 11 (5) :e0156604.

[18]JIANG YY, ZHANG XH, ZHENG SJ.Change in immune status after antiviral therapy in patients with hepatitis C virus infection[J].J Clin Hepatol, 2018, 34 (2) :403-406. (in Chinese) 蒋莹莹, 张晓慧, 郑素军.HCV感染者抗病毒治疗前后免疫状态的变化[J].临床肝胆病杂志, 2018, 34 (2) :403-406.

[19]SHEVACH EM, DIPAOLO RA, ANDERSSON J, et al.The lifestyle of naturally occurring CD4+CD25+Foxp3+regulatory Tcells[J].Immunol Rev, 2006, 212:60-73.

[20]READ S, GREENWALD R, IZCUE A, et al.Blockade of CTLA-4on CD4+CD25+regulatory T cells abrogates their function in vivo[J].J Immunol, 2006, 177 (7) :4376-4383.

[21]LI BT, XIAO L.Research progress of the relationship between CTLA-4, CTLA-4 polymorphism and HCV infection[J/CD].Chin J Clinicians:Electronic Edition, 2013, 7 (23) :10905-10908. (in Chinese) 李邦涛, 肖丽.细胞毒性T淋巴细胞相关抗原4及其基因多态性在丙型病毒性肝炎中的研究进展[J/CD].中华临床医师杂志:电子版, 2013, 7 (23) :10905-10908.

[22]DOUMBA PP, SERTI E, BOUTSIKOU M, et al.Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake[J].Cell Mol Life Sci, 2013, 70 (18) :3463-3474.

[23]DING J, SU J, ZHANG L, et al.Crocetin activates Foxp3through TIPE2 in asthma-associated Treg cells[J].Cell Physiol Biochem, 2015, 37 (6) :2425-2433.

[24]FAN T, HUANG X, LIU C, et al.Egress of murine regulatory Tcells from the thymus requires TIPE2[J].Biochem Biophys Res Commun, 2018, 500 (2) :376-383.

Relative Articles

[1]	Chuanfu QIN, Yali ZHAO, Lijuan LONG, Hua QIU. Mechanism of cytotoxic T lymphocyte－derived exosomes inhibiting hepatic stellate cell activation[J]. Journal of Clinical Hepatology, 2023, 39(10): 2340-2347. doi: 10.3969/j.issn.1001-5256.2023.10.011
[2]	Tianyu LI, Huimin YAN. Mechanism of action of forkhead box transcription factors in hepatocellular carcinoma and their prospects as treatment targets[J]. Journal of Clinical Hepatology, 2021, 37(4): 931-934. doi: 10.3969/j.issn.1001-5256.2021.04.044
[3]	Xiaoke RAN, Xinju CHEN, Yunxia ZHAO, Xin ZHANG, He YANG, Yiyao SUN, Xiaoqi CHEN. Expression and clinical significance of forkhead box A2 and forkhead box J2 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(6): 1342-1347. doi: 10.3969/j.issn.1001-5256.2021.06.025
[4]	Wang ShanShan, Zhang QingShan, Zhao SuXian, Kong LingBo, Ji Lei, Kong Li. The immunoregulatory effect of tumor necrosis factor-alpha-induced protein 8-like 2 in different liver diseases[J]. Journal of Clinical Hepatology, 2020, 36(2): 460-463. doi: 10.3969/j.issn.1001-5256.2020.02.050
[5]	Li Tian, Wu Yan, Ji Ting, Jin ZhenXiao. Role of FOXO1/3 in the pathogenesis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1842-1846. doi: 10.3969/j.issn.1001-5256.2019.08.043
[6]	Kong Li, Zhang YuZhuo, Jin Meng, Wang ShanShan, Du JingHua, Zhang YuGuo, Wang RongQi, Ren WeiGuang, Nan YueMin. mRNA expression and significance of tumor necrosis factor-alpha-induced protein 8-like 2 and forkhead box P3 in peripheral blood mononuclear cells in patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2019, 35(12): 2721-2724. doi: 10.3969/j.issn.1001-5256.2019.12.016
[7]	Li Yu, Zhang Hong, Li Zhu, Liu QingE, Wang Lu, Zhang Dan, Cao NingJia, Su Li. Influence of the Notch signaling pathway on CD8⁺T lymphocyte function in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2018, 34(2): 287-291. doi: 10.3969/j.issn.1001-5256.2018.02.014
[8]	Guo FeiBo, Wu JunZhu, Ai LiMing, Song Ying. Clinical significance of Th17/Treg and associated cytokines in peripheral blood in chronic hepatitis C patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 479-484. doi: 10.3969/j.issn.1001-5256.2017.03.017
[9]	Kong Li, Jin Meng, Zhao SuXian. Role of tumor necrosis factor- alpha- induced protein 8-like 2 in development and progression of liver and gastrointestinal tumors[J]. Journal of Clinical Hepatology, 2017, 33(1): 175-179. doi: 10.3969/j.issn.1001-5256.2017.01.041
[10]	Guo FeiBo. Change in peripheral blood CD4~+ regulatory T cells and its association with antiviral effect in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2016, 32(12): 2317-2321. doi: 10.3969/j.issn.1001-5256.2016.12.017
[11]	Liu Mei, Zhang LiLi, Chen Ming, Pan XiuCheng, Li Li. The expression of suppressor of cytokine signaling-1 mRNA in the peripheral blood mononuclear cells of patients with chronic hepatitis B infection[J]. Journal of Clinical Hepatology, 2011, 27(5): 500-502.
[12]	Chen RuiLin, Lin ShuMei, Zhang ShuLin, Ye Feng, Zhang Xi, Zhao YingRen. Detection of the replicative state of HBV in peripheral blood mononuclear cells by improving PCR[J]. Journal of Clinical Hepatology, 2008, 24(5): 328-331.
[14]	Cui Fang, Wang DongPing. Detection of HBV DNA in periphereal blood mononuclear cells of patients with hepatitis B by FQ-FCR and its significance[J]. Journal of Clinical Hepatology, 2006, 22(2): 97-98.
[16]	Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140.
[17]	Song MinNing, Luo MeiLan, Huang WenQi, Min Feng. The study of levels of IL-10, IL-12 and γ-IFN in the culture medium of peripheral blood mononuclear cells from HBeAg positive chronic asymptomatic HBV patient[J]. Journal of Clinical Hepatology, 2003, 19(3): 176-177.
[19]	Zhang KaiYu, Cai YanJun, Wang Feng, Xu Chang, Lu: MeiDe. Study on Relationship between Detection of Hepatitis B Virus Replicative Intermediates RNA and Hepatitis B Virus DNA in Peripheral Blood Mononuclear Cells in Patients with Hepatitis B Virus Infection[J]. Journal of Clinical Hepatology, 2001, 17(3): 149-151.
[20]	Zhang KaiYu, Wang Feng, Lou JinFeng, Cai YanJun, Lu: MeiDe. Detection of Hepatitis B virus Replicative Intermediates RNA in Peripheral Blood Mononuclear cells in patients with Hepatitis B virus Infection and its clinical significance[J]. Journal of Clinical Hepatology, 2000, 16(2): 88-90.

Supplements(0)

Cited By

Cited by

Periodical cited type(7)

1.	李加宁. Graves病患者肝功能不全的影响因素分析. 智慧健康. 2023(23): 89-91+100 .
2.	陈玫君，郭飞波. 慢性丙型肝炎患者基因型分布及相关基因型血清学指标分析. 中外医疗. 2021(10): 20-22+29 .
3.	王闪闪，张庆山，赵素贤，孔令波，纪雷，孔丽. 肿瘤坏死因子α诱导蛋白8样分子2在不同肝脏疾病中的免疫调控作用. 临床肝胆病杂志. 2020(02): 460-463 . 本站查看
4.	牛煦明. 浅议抗核周因子抗原片的筛选与临床价值. 人人健康. 2020(14): 170 .
5.	李莉华，孙瑞华，薛燕平，姚鹏. 外周血单个核细胞中TIPE2、Foxp3和CTLA-4的表达及相关分析. 临床和实验医学杂志. 2020(19): 2053-2056 .
6.	张念军. 应用荧光定量PCR检测血清中HCV-RNA的临床分析. 世界最新医学信息文摘. 2019(A2): 185-186 .
7.	孔丽，张玉卓，金萌，王闪闪，杜静华，张玉果，王荣琦，任伟光，南月敏. 肿瘤坏死因子α诱导蛋白8样分子2和叉头样转录因子3 mRNA在原发性肝癌患者外周血单个核细胞中的表达及意义. 临床肝胆病杂志. 2019(12): 2721-2724 . 本站查看

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1852) PDF downloads(295)

The mRNA expression of TIPE2, Foxp3, and CTLA-4 in peripheral blood mononucleated cells in patients with chronic hepatitis C and their clinical significance

DOI: 10.3969/j.issn.1001-5256.2019.02.016